ImpriMed Secures $23 Million in Series A Funding to Revolutionize Cancer Treatment with AI December 20, 2023
Amide Technologies Revolutionizes Peptide Synthesis with Novel Manufacturing Platform and Secures $16.5M in Funding December 15, 2023
Parse Biosciences Secures $50 Million in Series C Financing and Debt Facility to Propel Single Cell Sequencing Innovations December 15, 2023
Encellin Secures $9.9M in Funding to Advance Revolutionary EnCRT for Type 1 Diabetes December 15, 2023
Calyxo Inc. Secures $50 Million in Series D Funding for Innovative Kidney Stone Treatment December 13, 2023
Zafrens Secures $23 Million in Funding to Advance High-Resolution Drug Discovery with Z-Screen™ Platform December 13, 2023
Medefy Health Secures $10 Million in Series A Funding to Enhance Healthcare Benefits Navigation December 13, 2023
Odyssey Therapeutics Secures $101 Million in Series C Funding to Propel Immunomodulators and Oncology Medicines December 8, 2023
Seismic Therapeutic Secures $121 Million in Series B Funding for Advanced Immunology Drug Development December 6, 2023
